Minimal Residual Disease–based Treatment is Adequate for...

Klinische Pädiatrie 2014 / 11 Vol. 226; Iss. 6/7

Minimal Residual Disease–based Treatment is Adequate for Relapse-prone Childhood Acute Lymphoblastic Leukemia with an intrachromosomal amplification of chromosome 21: The experience of the ALL-BFM 2000 trial

Attarbaschi, A., Panzer-Grümayer, R., Mann, G., Möricke, A., König, M., Mecklenbräuker, A., Teigler-Schlegel, A., Bradtke, J., Harbott, J., Göhring, G., Stanulla, M., Schrappe, M., Zimmermann, M., Haa
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
226
Journal:
Klinische Pädiatrie
DOI:
10.1055/s-0034-1387795
Date:
November, 2014
File:
PDF, 546 KB
2014
Conversion to is in progress
Conversion to is failed